文献速递中医内科中药与中成药合理使用

知柏地黄颗粒通过调节免疫反应治疗阴虚热证大鼠

The Chinese herbal formula Zhibai Dihuang Granule treat Yin-deficiency-heat syndrome rats by regulating the immune responses.
PubMed 文献 · J Ethnopharmacol · 2018-05-02

该研究以腹腔注射高剂量三碘甲状腺原氨酸(T3)诱导SD大鼠阴虚热证(YDH)模型,给予知柏地黄颗粒(ZDG)治疗一周后,用iTRAQ结合2D LC-MS/MS筛选差异血清蛋白并用ELISA验证。结果共鉴定55个差异蛋白,其中26个在ZDG治疗后恢复正常,主要涉及免疫反应、补体激活和炎症调节。

要点

  • 知柏地黄颗粒可能通过调节补体激活与炎症反应缓解阴虚热证。
  • ZDG治疗使26个差异表达蛋白在YDH大鼠中恢复正常水平。
  • ELISA验证Azgp1、L-selectin、Crp、Plg、Kng1升高,Mbl2、C1qb降低。

核心结论

  • 知柏地黄颗粒可能通过调节补体激活与炎症反应、促进抗原识别能力来缓解阴虚热证。

研究设计与样本

  • 研究采用高剂量三碘甲状腺原氨酸(T3)腹腔注射诱导SD大鼠阴虚热证模型,随后以知柏地黄颗粒治疗一周。
  • 采用iTRAQ结合二维液相色谱-串联质谱(2D LC-MS/MS)筛选差异血清蛋白,并用ELISA验证。

主要发现

  • 共鉴定55个差异表达蛋白,包括23个上调蛋白(>1.25倍,p<0.05)和32个下调蛋白(<0.80倍,p<0.05)。
  • 其中26个差异蛋白在知柏地黄颗粒治疗后恢复正常。
  • 生物信息学分析显示差异蛋白主要参与免疫反应,包括免疫系统过程调节、补体激活和循环免疫球蛋白介导的体液免疫反应。
  • ELISA显示ZDG治疗组较YDH模型组Azgp1、L-selectin、Crp、Plg、Kng1水平显著升高,Mbl2和C1qb水平显著降低。

关键数值与推荐

  • 差异表达蛋白筛选标准:上调>1.25倍且p<0.05,下调<0.80倍且p<0.05。
  • ELISA验证蛋白中,Azgp1参与抗原加工与呈递,Crp、C1qb、Mbl2参与补体激活,L-selectin、Plg、Kng1参与炎症反应调节。

临床怎么用

  • 知柏地黄颗粒治疗阴虚热证可能通过调节补体激活和炎症反应相关蛋白发挥作用。
  • Azgp1、L-selectin、Crp、Plg、Kng1、Mbl2、C1qb等可作为探索知柏地黄颗粒免疫调节机制的候选蛋白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Zhibai Dihuang Granule (ZDG), a traditional Chinese medicine (TCM) made from eight Chinese herbs, has been classically used to treat Yin-deficiency-heat (YDH) syndrome. ZDG is well known with the therapeutic efficacy of nourishing Yin and decreasing internal heat in clinic, but the mechanism of ZDG's therapeutic effect is still not clear. MATERIALS AND METHODS: High doses of triiodothyronine (T3) were given intraperitoneally to induce Hyperthyroid YDH syndrome in SD rats. The animals were then treated with ZDG for one week. The iTRAQ-coupled with two-dimensional liquid chromatography-tandem mass spectrometry (2D LC-MS/MS) technique was used to screen the differentially expressed serum proteins between ZDG treated rats and YDH syndrome rats. The differentially expressed proteins were analyzed by bioinformatics method and were verified by enzyme-linked immunosorbent assay (ELISA). RESULTS: A total of 55 differentially expressed proteins were identified, including 23 up-regulated proteins (>1.25 fold, p < 0.05) and 32 down-regulated proteins (<0.80 fold, p < 0.05). Among the differentially expressed proteins, 26 proteins returned to normal after ZDG treatment. Bioinformatics analysis showed that these proteins were mainly involved in immune response, including regulation of immune system process, complement activation, and humoral immune response mediated by circulating immunoglobulin. ELISA revealed significantly increased levels of Zinc-alpha-2-glycoprotein (Azgp1), L-selectin, C-reactive protein (Crp), Plasminogen (Plg), Kininogen 1 (Kng1), and significantly decreased levels of Mannose binding lectin 2 (Mbl2) and Complement C1qb chain (C1qb) in ZDG treated rats compared with YDH syndrome rats. Bioinformatics analyses indicated that Azgp1 participated in antigen processing and presentation, Crp, C1qb, and Mbl2 were involved in complement activation, while L-selectin, Plg, and Kng1 were involved in regulating the inflammatory response. CONCLUSIONS: Our study provides experimental evidence to understand the therapeutic mechanism of ZDG in YDH syndrome. The results suggested that ZDG may regulate the complement activation and inflammatory response, and promote the ability to recognize antigens to alleviate YDH syndrome.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Liu CM, Chen J, Yang S, et al. The Chinese herbal formula Zhibai Dihuang Granule treat Yin-deficiency-heat syndrome rats by regulating the immune responses. J Ethnopharmacol. 2018. PMID: 29729385. doi:10.1016/j.jep.2018.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。